Biomea Fusion, Inc. (BMEA)
0.8689
+0.03
(+3.89%)
USD |
NASDAQ |
Oct 16, 16:00
0.8899
+0.02
(+2.42%)
After-Hours: 20:00
Biomea Fusion Net Income (TTM) : -32.54M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.54M |
| March 31, 2026 | -44.95M |
| December 31, 2025 | -61.80M |
| September 30, 2025 | -95.71M |
| June 30, 2025 | -112.09M |
| March 31, 2025 | -128.63M |
| December 31, 2024 | -138.43M |
| September 30, 2024 | -144.01M |
| June 30, 2024 | -139.65M |
| March 31, 2024 | -127.26M |
| December 31, 2023 | -117.26M |
| September 30, 2023 | -107.68M |
| Date | Value |
|---|---|
| June 30, 2023 | -102.15M |
| March 31, 2023 | -94.51M |
| December 31, 2022 | -81.83M |
| September 30, 2022 | -71.22M |
| June 30, 2022 | -60.94M |
| March 31, 2022 | -52.08M |
| December 31, 2021 | -41.57M |
| September 30, 2021 | -30.36M |
| June 30, 2021 | -18.88M |
| March 31, 2021 | -10.78M |
| December 31, 2020 | -5.324M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| REGENXBIO, Inc. | -196.43M |
| Compass Therapeutics, Inc. | -73.45M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |